You are here

Article info

Article menu

This article has a correction. Please see:

XML
Epidemiology
Research
Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010

Authors

  1. Correspondence to Dr V Ehrenstein; ve{at}dce.au.dk
View Full Text

Citation

Ehrenstein V, Hernandez RK, Ulrichsen SP, et al
Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010
BMJ Open 2013;3:e003424. doi: 10.1136/bmjopen-2013-003424

Publication history

  • Received June 17, 2013
  • Revised August 8, 2013
  • Accepted August 9, 2013
  • First published September 24, 2013.
Online issue publication 
October 25, 2017
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/